Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.46 |
| ▸ | CA1 | P00915 | 3/20 | 0.44 |
| ▸ | CA12 | O43570 | 2/20 | 0.44 |
| ▸ | CA9 | Q16790 | 2/20 | 0.44 |
| ▸ | STAT3 | P40763 | 2/20 | 0.43 |
| ▸ | RECQL | P46063 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 2/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.38 |
| ▸ | PPARG | P37231 | 1/20 | 0.38 |
| ▸ | PSMD10 | O75832 | 1/20 | 0.38 |
| ▸ | CA2 | P00918 | 2/20 | 0.38 |
| ▸ | MMP2 | P08253 | 2/20 | 0.38 |
| ▸ | MMP9 | P14780 | 2/20 | 0.38 |
| ▸ | MMP8 | P22894 | 2/20 | 0.38 |
| ▸ | MMP13 | P45452 | 2/20 | 0.38 |
| ▸ | MMP1 | P03956 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30244568 | 1.00 | ALDH1A1 (0.46) | ALDH1A1CA1CA12CA9STAT3 | |
| SCHEMBL16898428 | 1.00 | ALDH1A1 (0.46) | ALDH1A1CA1CA12CA9STAT3 | |
| SCHEMBL15416739 | 1.00 | ALDH1A1 (0.46) | ALDH1A1CA1CA12CA9STAT3 | |
| SCHEMBL483840 | 1.00 | ALDH1A1 (0.46) | ALDH1A1CA1CA12CA9STAT3 | |
| SCHEMBL1742594 | 1.00 | ALDH1A1 (0.46) | ALDH1A1CA1CA12CA9STAT3 | |
| SCHEMBL916053 | 1.00 | ALDH1A1 (0.46) | ALDH1A1CA1CA12CA9STAT3 | |
| SCHEMBL23417950 | 1.00 | ALDH1A1 (0.46) | ALDH1A1CA1CA12CA9STAT3 | |
| SCHEMBL7519771 | 1.00 | ALDH1A1 (0.46) | ALDH1A1CA1CA12CA9STAT3 | |
| SCHEMBL11516145 | 1.00 | ALDH1A1 (0.46) | ALDH1A1CA1CA12CA9STAT3 | |
| SCHEMBL16899885 | 1.00 | ALDH1A1 (0.46) | ALDH1A1CA1CA12CA9STAT3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 336 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4678665-A1 | A POLYMER, PREPARATION METHOD THEREOF, POROUS MEMBRANE CONTAINING THE POLYMER AND APPLICATION OF THE MEMBRANE | Syai UK Ltd (GB) | 2026-01-14 | — | — | EP | claimed |
| CN-118684823-A | Polymer, preparation method thereof, porous membrane containing polymer and application of membrane | 欧态科技(无锡)有限公司 | 2024-09-24 | — | — | CN | claimed |
| CN-117772154-A | Packing for glycosylated hemoglobin chromatographic column and preparation method thereof | 无锡博慧斯生物医药科技有限公司 | 2024-03-29 | — | — | CN | claimed |
| CN-117049967-A | Preparation method and active application of 2, 6-dinitro-3, 4-dimethylphenol derivative | 西华大学 | 2023-11-14 | — | — | CN | claimed |
| US-20230303792-A1 | Additive for Reducing Polyurethane Foam Degradation | HUNTSMAN INTERNATIONAL LLC | 2023-09-28 | — | — | US | claimed |
| EP-4196514-A1 | ADDITIVE FOR REDUCING POLYURETHANE FOAM DEGRADATION | Huntsman International LLC (US) | 2023-06-21 | — | — | EP | claimed |
| US-20230078913-A1 | ANDROGEN RECEPTOR MODULATORS AND METHODS FOR USE AS PROTEOLYSIS TARGETING CHIMERA LIGANDS | ESSA PHARMA INC. (CA) | 2023-03-16 | — | — | US | claimed |
| CN-114269331-A | Androgen receptor modulators and methods of use as proteolytic targeting chimeric ligands | 埃萨制药股份有限公司 | 2022-04-01 | — | — | CN | claimed |
| WO-2022034151-A1 | ADDITIVE FOR REDUCING POLYURETHANE FOAM DEGRADATION | HUNTSMAN INTERNATIONAL LLC (US) | 2022-02-17 | — | — | WO | claimed |
| EP-3946292-A1 | ANDROGEN RECEPTOR MODULATORS AND METHODS FOR USE AS PROTEOLYSIS TARGETING CHIMERA LIGANDS | Essa Pharma, Inc. (CA) | 2022-02-09 | — | — | EP | claimed |
| WO-2020198711-A1 | ANDROGEN RECEPTOR MODULATORS AND METHODS FOR USE AS PROTEOLYSIS TARGETING CHIMERA LIGANDS | ESSA PHARMA, INC. (CA) | 2020-10-01 | — | — | WO | claimed |
| EP-3658548-A1 | COMPOUNDS AND METHODS FOR THE TARGETED DEGRADATION OF ANDROGEN RECEPTOR | Arvinas Operations, Inc. (US) | 2020-06-03 | — | — | EP | claimed |
| CN-111205472-A | Preparation method of solid fluorescent dye based on multiple hydrogen bonds | 常州大学 | 2020-05-29 | — | — | CN | claimed |
| WO-2019023553-A1 | COMPOUNDS AND METHODS FOR THE TARGETED DEGRADATION OF ANDROGEN RECEPTOR | Arvinas, Inc. (US) | 2019-01-31 | — | — | WO | claimed |
| US-20170327469-A1 | COMPOUNDS AND METHODS FOR THE TARGETED DEGRADATION OF ANDROGEN RECEPTOR | ARVINAS OPERATIONS, INC. | 2017-11-16 | — | — | US | claimed |
| US-20260115296-A1 | COMPOUNDS AND METHODS FOR THE TARGETED DEGRADATION OF RAPIDLY ACCELERATED FIBROSARCOMA POLYPEPTIDES | UNIV YALE (US) | 2026-04-30 | — | — | US | disclosed |
| US-20260055097-A9 | NRF2 PROTEIN DEGRADERS | GANYMEDE ONCOLOGY INC (US) | 2026-02-26 | — | — | US | disclosed |
| WO-1999061912-A1 | MOLECULAR ROD AND USES | COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) | 1999-12-02 | — | — | WO | disclosed |
| EP-0824537-A1 | IODINE DERIVATIVES OF MONOSACCHARIDES USEFUL AS RADIOPHARMACEUTICAL PRODUCTS | CIS BIO INTERNATIONAL (FR) | 1998-02-25 | — | — | EP | disclosed |
| WO-1996034872-A1 | IODINE DERIVATIVES OF MONOSACCHARIDES USEFUL AS RADIOPHARMACEUTICAL PRODUCTS | CIS BIO INTERNATIONAL (FR) | 1996-11-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230078913-A1 | ANDROGEN RECEPTOR MODULATORS AND METHODS FOR USE AS PROTEOLYSIS TARGETING CHIMERA LIGANDS | AR, PSMA1, SHBG | ALDH1A1 3367/4885CA1 3020/4885CA12 2897/4885 |
| US-20170327469-A1 | COMPOUNDS AND METHODS FOR THE TARGETED DEGRADATION OF ANDROGEN RECEPTOR | AR, MDM2, ESRRA | ALDH1A1 514/4885CA1 2519/4885CA12 2708/4885 |
| US-20260055097-A9 | NRF2 PROTEIN DEGRADERS | KEAP1, NFE2L2, NFE2 | ALDH1A1 1094/4885CA1 3789/4885CA12 3947/4885 |
| US-20260115296-A1 | COMPOUNDS AND METHODS FOR THE TARGETED DEGRADATION OF RAPIDLY ACCELERATED FIBROSARCOMA POLYPEPTIDES | CRBN, VHL, ADRM1 | ALDH1A1 2777/4885CA1 3147/4885CA12 3515/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.